Verses to release Atari benchmark results at World Economic Forum
Verses AI's (CBOE:VERS) chief scientist, Karl Friston, with senior leadership, will be attending the World Economic Forum.
A Look into the Future of Chronic Pain Management
An interview with Innocan Pharma’s CEO, Iris Bincovich, about the company's innovative pain relief solutions.
BCG-Unresponsive Non-Muscle Invasive Bladder Cancer Carcinoma-In-Situ: A Patient’s Guide
As a patient with BCG-Unresponsive NMIBC CIS, bladder removal is far from the only option on the table in 2024.
NervGen Pharma: Proof that NVG-291 works?
Tantalizing anecdotal “evidence” has just been published suggesting that NervGen’s prospective wonder-drug, NVG-291, is delivering the goods.
Brianne Gardner’s 2025 stock picks
Brianne Gardner, Senior Wealth Manager at Velocity Investments, Raymond James Canada gives three new stocks to add to your 2025 Watchlist.
A critical minerals stock to future-proof your portfolio
This critical minerals stock offers investors numerous projects poised to capture significant upside as ESG principles become table stakes.
In conversation with: Pierre Gratton: How can we built more mines faster in Canada?
The Mining Association of Canada’s President and CEO Pierre Gratton discusses ,"How can we build more mines faster?
BoC’s Double Rate Cut: Is it a benefit for Canadians
The Bank of Canada (BoC) has implemented a 50-basis-point interest rate cut. This is in responds...
NurExone Biologic announces important test results
NurExone Biologic (TSXV:NRX; OTCQB:NRXBF) is developing its ExoPTEN to treat patients with acute spinal cord injuries.
New research report on Nextech3D.AI by H.C. Wainwright & Co.
Delve into the new research report on Nextech3D.AI (CSE:NTAR) by H.C. Wainwright & Co.